Contact

Click here for a confidential contact or call:

1-347-417-2192

Firm News

Constantine Cannon lawyers are regularly quoted in a variety of publications.  We have collected some of these appearances here, along with other firm news.

Page 2 of 66

Constantine Cannon Announces Record $70 Million Whistleblower Settlement for Alleged Municipal Bond Fraud and Price Fixing

Posted  03/22/24
The Constantine Cannon whistleblower team is pleased to announce a $70 million settlement for its client Edelweiss Fund LLC in a whistleblower lawsuit against eight of the nation's largest banks, making it the largest reported settlement ever under the Illinois False Claims Act.  Constantine Cannon originally filed the action in 2014 and since then has built up the Edelweiss legal team with multiple firms across the...
Read More

Constantine|Cannon Files Historic Antitrust Litigation Targeting Exploitation of Major Junior Hockey Players

Posted  02/14/24
Constantine|Cannon LLP, along with five other leading antitrust and labor law firms, filed a landmark antitrust case in New York federal court today, aimed at exposing what plaintiffs allege to be egregiously anticompetitive collusion that targets teenage players across North America. The class action lawsuit, which names as defendants the National Hockey League, the Canadian Hockey League, the Ontario Hockey...
Read More

February 12, 2024

Whistleblower partner Gordon Schnell quoted in Compliance Week on the broad implications for whistleblowers and employers flowing from the Supreme Court’s decision in Murray v. UBS, which concerned the standard for bringing retaliation claims under the Sarbanes-Oxley Act (subscription required).

February 8, 2024

Whistleblower partner Gordon Schnell quoted in Law360 on the significance of the Supreme Court’s decision in Murray v. UBS which confirmed the lower standard whistleblowers must meet to bring successful retaliation claims under the Sarbanes-Oxley Act (subscription needed).

Update on FDA-Related Qui Tams and the False Claims Act (FCA)

Posted  12/7/23
On Dec. 7, Hamsa Mahendranathan appeared on a panel titled "Update on FDA-Related Qui Tams and the False Claims Act (FCA)" at the Food and Drug Law Institute’s Enforcement, Litigation, and Compliance Conference in Washington, D.C.

Whistleblowers: Who Are They and What Makes a Good Whistleblower Case

Posted  11/5/23
On Nov. 5, Michael Ronickher spoke on the panel "Whistleblowers: Who Are They and What Makes a Good Whistleblower Case” at the Healthcare Enforcement Compliance Conference.
1 2 3 4 … 66

Newsletter

Subscribe to receive email updates from the Constantine Cannon blogs

Sign up for: